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Background
Meibomian gland is the largest sebaceous glands in the human body. Meibomian glands 
synthesize and secrete a mixture of lipids, termed meibomian oil or meibum [1], which 
is delivered as a clear liquid via orifices located directly in front of the mucocutane-
ous junction. Meibomian gland diseases are subdivided into focal lesion and diffuse 
lesion. The former refers to hordeolum or chalazion and the latter is meibomian gland 
dysfuction (MGD). MGD is a chronic, diffuse of meibomian gland lesions, of which 
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pathological basis is meibomian gland terminal duct obstruction and (or) qualitative or 
quantitative change of meibum secretion [2]. It can cause abnormal tear film, eye irrita-
tion and ocular surface inflammation. More seriously, MGD can cause the ocular sur-
face damage of visual function. At present, the prevalence of MGD in association with 
dry eye varies greatly, ranging from 3.5% in the Salisbury Eye Evaluation Study [3] to 
60.8% in the Shihpai Eye Study in Taiwan [4], 68.3% in the Beijing Eye Study in China [5], 
and 56.3% in the Singapore Malay Eye Study [6]. MGD was highly in Asian population 
and associated with various systemic and ocular conditions, such as postmenopausal 
women, pinguecula, high diastolic blood pressure, anterior blepharitis, corneal contact 
lens and Demodex mites [6].
As we all know, the tear film lipid layer (TFLL) forms the outermost layer of the film 
and is composed of both polar and nonpolar lipids. It has been accepted that the TFLL 
is an indispensable component of the tear film, providing a smooth optical surface for 
the cornea and retarding evaporation from the eye [7]. Although the precise aetiology of 
MGD remain to be undetermined, as reported, MGD is a chronic, diffuse abnormality 
of the Meibomian glands, commonly characterised by terminal duct obstruction and (or 
qualitative) quantitative changes in the glandular secretion. It may result in alteration of 
the tear film, symptoms of eye irritation, clinically apparent inflammation, and ocular 
surface disease [8]. In a recent review, five separate pathophysiological mechanisms of 
MGD resulting from tear film instability were reported, eyelid inflammation, conjunc-
tival inflammation, corneal damage, microbiological changes and dry eye disease (DED) 
[9]. The underlying pathophysiological mechanisms of DED and MGD interact, resulting 
in a double vicious circle. This is consistent with the high incidence of advanced stage 
MGD.
Dry eye disease is a common condition that occurs when the eyes don’t make enough 
tears, or the tears evaporate too quickly. It is now generally accepted that there are 
two major classifications of DED: aqueous deficient and evaporative dry eye [10–12]. 
Rather, DED a term that describes a range of conditions with multiple possible etiologies 
and comorbidities. Additionally, MGD is one of the most common diseases observed 
in clinics and is the leading cause of evaporative dry eye [13]. MGD occurs when the 
Meibomian glands, located in the eyelids, do not sufficiently produce and release the 
oils needed to protect and maintain a healthy tear film. This causes the watery layer in 
the tear film to evaporate. Thus, the problem for many dry eye patients is not inade-
quate tear production, as thought for so many years, but a lack of oil production that 
ensures the protective integrity of the tear film is maintained on a daily basis. Given the 
increased recognition of the importance of MGD, a great amount of attention has been 
paid to diagnosis and therapies targeting this condition.
Materials
Subject recruitment
The analysis made use of 228 images of 57 patients recorded by OCULUS  Keratograph® 
5 M with a resolution of M × N=1024 × 1360 pixels (where M—the number of rows, 
N—the number of columns). The obtained images LRGB(m,n,k) (where m—row, n—
column, k—color) concern 30 eyes of healthy individuals (14 women and 16 men) and 
27 eyes of sick patients (10 women and 17 men). The diagnosis of dry eye was made 
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according to the consensus of DED in China (2013): (1) at least 1 of 6 symptoms: dry-
ness, burning, sandiness, tiredness, discomfort, and blurred vision with fluorescein tear 
breakup time ≤5 s or a non-anesthesia Schirmer I test value ≤5 mm/5 min; (2) at least 
1 of 6 symptoms: dryness, burning, sandiness, tiredness, discomfort, and blurred vision 
with 5 s< fluorescein tear breakup time ≤10 s or 5 mm/5 min< non-anesthesia Schirmer 
I test ≤10 mm/5 min, accompanied by corneal fluorescein staining score. The diagnostic 
criteria of MGD were as follows: (1) symptoms of ocular discomfort: itching or photo-
phobia with limitations of activities; (2) clinical signs: at least 1 lid margin feature (plug-
ging, vascularity), meibum quality: grade: ≥4, expressibility: ≥1. Potential subjects were 
excluded from the study if they had undergone previous corneal or ocular surgery, had 
any ocular pathology other than DED and DI, had systemic diseases known to affect 
the eye. Participants were instructed to remove soft contact lenses at least 2 weeks and 
rigid contact lenses at least 1 month before the examination. Data were collected from 
August 2015 to May 2016 in Beijing Tongren Hospital, Beijing, China. All participants 
signed an informed consent form in accordance with the tenets of the Declaration of 
Helsinki and this study was approved by the institutional review board of Beijing Ton-
gren Hospital, Beijing, China. The analysis was conducted in the Matlab environment 
Version 7.11.0.584, R2010b, Java VM Version: Java 1.6.0_17-b04 with Sun Microsystems 
Inc. with toolboxes: Statistical, Signal Processing i Image Processing.
Examinations
Each patient finished 3 parts of the clinical examination: (1) Ocular surface evaluation: 
the Ocular Surface Disease Index (OSDI) Survey and fluorescein staining. (2) tear func-
tion assessment: fluorescein tear breakup time (BUT), non-anesthetized Schirmer I test 
(S|T); (3) meibomian gland function assessment: meibum quality, meibomian gland 
expressibility; meibomian gland dropout.
Ocular surface evaluation
Ocular surface disease index
Before the other clinical examinations, patients were required to complete the Ocular 
Surface Disease Index (OSDI) Survey. This questionnaire gives a range of 0 (no symp-
toms) to 100 (severe symptoms).
Corneal fluorescein staining
Corneal fluorescein staining was graded from 0 to 12, a sum of the scores of corneal four 
quadrants, which were scored individually as 0 (no staining), 1 (mild staining with a few 
scattered dots of stains), 2 (moderate staining between 1 and 3), and 3 (severe staining 
with confluent stains or corneal filaments) [13].
Tear function assessment
Schirmer I test
The SIT was a useful assessment of aqueous tear production. The inferior conjunctival 
fornix was dried with a cotton stick. One minute later, a standard 5 × 40 mm Schirmer 
test strip was placed over the junction of the middle and outer third of inferior lid. The 
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patients are instructed to keep their eyes closed during the test. The test lasted 5 min, 
and the amount wetting was recorded [14].
Fluorescein tear breakup time
BUT is the time interval between the last blink and the appearance of the first random 
dry spot on the corneal surface after the instillation of fluorescein. The average of three 
consecutive FBUT values was calculated [15].
Meibomian gland function measurement
The following three parameters were the most commonly used methods to evaluate the 
morphological characteristics and function of Meibomian glands in clinical practice: 
abnormalities of lid margins, expression of meibum, and gland dropout degree visual-
ized by meibography [16].
Lid margin
Lid margin abnormality was recorded according to the existence of the following four 
signs: lid margin irregular, vascular engorgement, glandular orifices obstruction, and 
anterior or posterior displacement of the mucocutaneous junction, the scored was from 
0 to 4 [17].
Meibum expression
The quality of the expression of meibum was assessed semiquantitatively in 8 glands 
of the central third area of the lower eyelids: Grade 0 clear fluid, Grade 1 cloudy fluid, 
Grade 2 cloudy, particulate fluid, and Grade 3 inspissated, toothpaste-like fluid [18].
Methods and results
The presented method of analysis is a new, developed method enabling an automatic, 
reproducible and quantitative assessment of Meibomian glands [18–24]. The analysis 
relates to employing the methods of analysis and image processing [25–35]. The new, 
proposed method of image analysis was divided into three stages:
  • Image acquisition,
  • Initial image processing,
  • Major image processing.
Particular stages will be comprehensively described in subsequent subunits.
Image acquisition
Image acquisition was conducted in Beijing Tongren Hospital in China [36]. Each patient 
was sitting still in front of Keratograph 5 M. The ophthalmologist was simultaneously 
performing the examination and recording the images everting the upper and lower lid 
of the left and right eye of the patient. In total, 228 images of left and right eye of both 
upper and lower lid were obtained from 57 patients. The recorded sequence of images 
EX0000*.zip was automatically decompressed to acquire the images of lower lowerLid.
BMP and upper lid upperLid.BMP. The names of the files are fixed for each patient. In 
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the next stage of image processing, the algorithm works independently of the lid (lower 
or upper) and eye (right or left). The image inserted into the workspace (of lower or 
upper lid) will be further described as LRGB (m,n,k).
Initial image processing
Initial image processing was linked to three stages: filtering with median filter, normali-
zation and removing uneven illumination [37–39]. Filtration with median filter was per-
formed with the use of hMED mask of the size MMED × NMED = 3 × 3 pixels [40]. The 
output image LMED (m,n,i) was further normalized i.e. the image after normalization 
LNORM (m,n,i) will be equal to:
The last stage of the initial image processing is removal of uneven illumination. Illu-
mination unevenness is clearly visible almost in every image [20]. In practice in order 
to remove it, the deduction of the result of low-pass filtration LGROUND (m,n,i) from 
the input image, in this case LNORM (m,n,i), is applied, i.e. the image after removal of 
unevenness:
where:
⊖ erosion, SE structural element of the size of MSE × NSE = 31 × 31 pixels. The output 
image LNLOW (m,n,i) is further subject to major image processing.
Major image processing
Major image processing was performed on the basis of two images: LGRAY (m,n,i) and 
LNLOW (m,n,i). The second one was destined to detect the location of Meibomian glands 
which are usually arranged vertically (although there may also be other arrangements) 
in relation to the image plane (positioning of the patient). The analysis is based on using 
Riesz pyramid i.e. hR mask defined as:
where σm,σn,σα standard deviation of the mean for three dimensions m,n,α, α mask rota-
tion angle, mR, nR, αR normalized values m, n,α up to the range from −0.5 to 0.5, i.e. for 
example for mR:
(1)LNORM(m, n, i) =
LNORM(m, n, i)−min
m,n
(LMED(m, n, i))
max
m,n
(
LNORM(m, n, i)−min
m,n
(LMED(m, n, i))
)
(2)LNLOW (m, n, i) = |LNORM(m, n, i)− LGROUND(m, n, i)|
(3)LGROUND(m, n, i) = LNORM(m, n, i)⊖SE
(4)hR (mR, nR,αR, σm, σn, σα) = 1
σm, σn, σα(2 · pi)
3
2
· exp
(
−
m2R
2 · σ 2m
−
n2R
2 · σ 2n
−
σ 2R
2 · σ 2α
)
(5)mR =
m
M
− 0.5
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Riesz pyramid enables creating mask sequences which in turn allow separat-
ing Meibomian glands located at various angles relative to image plane and privi-
leged vertical position. In Fig.  1 an exemplary pyramid of hR mask defined for 
hRσm = 0.05,σn = 0.05,σα = 0.4 and second derivative calculated after variable m is pre-
sented. The obtained results, other forms of hR mask, are shown in Fig. 2 for other exem-
plary values σm,σn and σα. The obtained results, images LRIESZ (m,n,i), resulting from the 
hR mask convolution for exemplary eye images LNLOW (m,n,i) are shown in Fig. 3.
The next stage is to designate the area covered by the Meibomian glands. In this case 
the image LRIESZ (m,n,i) will be subject to averaging based on the structural element SE. 
This operation will encompass the substitution of areas for which the maximum values 
of matrix LRIESZ (m,n,i) have exceeded the set threshold pr by the value of ‘1’. Therefore, 
the resulting matrix LRES (m,n,i) is equal to:
(6)LRES(m, n, i) =
{
1 if max
mS,nSSE
(LRIESZ(m+mS , n+ nS , i))>pr
0 other
Fig. 1 Riesz pyramid, hR mask defined for σm = 0.05,σn = 0.05,σα = 0.4 and its second derivative calculated 
after variable m: a graph of the pyramid of hR masks sequence in the coordinate system defined for pixel 
units; b hR mask in the 2D graph for α = 0o; c for α = 20o; d for α = 40o; e for α = 60o; f for α = 80o
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where mS and nS rows and columns of SE mask of the size MS × NS.
Calculating the maximum value in the area of SE mask causes averaging of the infor-
mation about the location of particular Meibomian glands. Therefore, there occurs 
Fig. 2 hR mask defined for a σm = 0.05,σn = 0.05,σα = 0.05; b σm = 0.05,σn = 0.1,σα = 0.05; c 
σm = 0.01,σn = 0.1,σα = 0.05; d σm = 0.1,σn = 0.05,σα = 0.1; and its second derivative calculated after variable m
Fig. 3 Exemplary input image LGRAY (m,n,i) a and obtained results LRIESZ (m,n,i) b being the convolution for 
exemplary images LNLOW (m,n,i) with hR mask defined for σm = 0.05,σn = 0.05,σα = 0.4 and its second deriva-
tive calculated after variable m
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globalization of the information concerning the position of Meibomian glands on the lid. 
However, as a result of this operation there also occurs the covering of the edge of the 
eyelid, and therefore it must be automatically removed from the resulting analysis. The 
position of the eyelid edge was calculated as a result of the xor operation between two 
binary images LRES (m,n,i) and its result of dilation. The binary image of the edge of the 
eyelid LBP (m,n,i) therefore equals:
where ⊕ dilation operator.
The structural element SE2 of the size of MS2 × NS2 = 60 × 60 pixels with the center of 
coordinate system placed in the middle of the first row.
The last operation is to establish the Bézier curve allowing the separation of the area 
of upper and lower lid—according to Fig. 4. In Fig. 4a a demonstrative image with char-
acteristic automatically recognized areas is presented: 1,2 area and Bézier curve of the 
lower eyelid boundary; 3,4—are and Bézier curve of upper eyelid boundary; 5—eyelid 
edge area. Summing up, the new, proposed automatic method of analysis enables auto-
matic calculation of:
  • Area occupied by Meibomian glands,
  • Area occupied by the eyelid edge,
  • Area occupied by the eyelid.
The conducted analysis, particularly the percentage area occupied by Meibomian 
glands in relation to the whole surface of the eyelid (upper and lower respectively) con-
stitutes the most important result of the proposed new algorithm. In order to determine 
if the patient is ill or healthy the‚ cut-off’ threshold—po was set. Above the po threshold 
the patients are considered to be healthy, while below the threshold they are considered 
ill. The result will be compared with the analysis conducted manually by specialized 
doctors from Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing 
(7)LBP(m, n, i) = (LRES(m, n, i)⊕ SE2)∨LRES(m, n, i)
Fig. 4 Image analysis results: a a demonstrative image showing the location of characteristic, automatically 
recognized areas: 2 Bézier curve of the lower eyelid boundary and the area 1 marked by it; 4 Bézier curve of 
the upper eyelid boundary and the area 3 marked by it; 5 area of eyelid edge; b image LNLOW (m,n,i) where 6- 
eyelid edge area; 7 the results of manual indication of Meibomian glands area determined by an expert and 8 
the area occupied by them calculated automatically
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Tongren Hospital in China. The results of comparison are shown for exemplary patients 
in Table 1. In Fig. 4b a demonstrative image LNLOW (m,n,i) was shown with marked dig-
its: 6—area of eyelid edge; 7—the results of manual indication of Meibomian glands area 
determined by an expert together with the area occupied by them calculated automati-
cally 8. The obtained results in Table 1 concern both healthy and ill patients. According 
to the expert’s decision they were divided into two groups:
  • Group of healthy individuals—Meibomian glands occurring on the whole surface of 
the eyelid,
  • Group of sick individuals—Meibomian glands not occurring on the whole eyelid sur-
face.
The results of specificity SPC and sensitivity TPR as well as accuracy defined as 
ACC = (TN + TP)/(TN + TP + FN + FP) where: TN—true negative, TP—true positive, 
FN—false negative and FP—false positive. The obtained results for 57 patients from 228 
images of left and right eye are presented in Table 2. The ROC curve (receiver operat-
ing characteristic) as a relationship between sensitivity and specificity for the changed 
threshold po in the range from 0 to 100% is shown in Fig. 5. 
Discussion
The developed algorithm was compared with the method proposed in [41]. In the 
method described in [41] the results of sensitivity were obtained at the level of 99.3% and 
specificity at 97.5% in the diagnostics of Meibomian glands. The algorithm presented in 
[41] is not insensitive to the change of parameters, while the speed of image analysis for 
one patient, according to the Authors’ declaration, does not exceed 0.5 s. This attitude 
however has disadvantages which involve the necessity of analyzing the location and 
Table 1 Exemplary obtained results of  manual and  automatic analysis of  Meibomian 
glands presented in this article
Patient 
number
Eye—left/
right
Eyelid—up/
down
Eyelid sur-
face (pixel)
Meibomian 
glands sur-
face (pixel)
Percentage 
area of Mei-
bomian 
glands (%)
Expert’s 
analysis result 
(healthy/Ill)
1 Left Up 59,849 20,131 33 Healthy
2 Left Down 42,993 13,283 30 Healthy
9 Right Up 238,269 81,618 34 Healthy
10 Right Down 48,207 18,449 38 Healthy
14 Right Down 138,953 28,272 20 Ill
15 Right Up 206,472 52,585 25 Ill
16 Right Down 105,846 26,667 25 Ill
Table 2 Obtained results of  sensitivity, specificity and  accuracy for  the analyzed images 
for po = 26%
Parameter Value (%)
SPC 100
TPR 98
ACC 99.08
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centerlines of Meibomian glands. The method presented in this article (new algorithm) 
based on Riesz pyramid of masks is not only faster (average time of analysis for computer 
with Windows 7 Professional, 64-bit with the Intel Core i7-4960X CPU @ 3.60 GHz is 
0.4 s—CPU and memory utilization were the same [41]) but also allows obtaining bet-
ter sensitivity results equaling 98% and specificity equaling 100%. In Fig.  6 exemplary 
results comparing two methods are presented: (a) images with automatically marked 
position of Meibomian glands according to the method described in [41]; (b) area cov-
ering Meibomian glands according to the method described in [41] and (c) results of 
the analysis described in this article (indications complying with indications in Fig. 6b. 
The key difference visible during comparison of the results is the way of analysis of the 
areas occupied by Meibomian glands. For the method described in [41] it is also the area 
occupied by the eyelid edge and therefore included in the area of Meibomian glands. For 
bigger areas of glands the values are of no significance. However, for small areas occu-
pied by Meibomian glands it is of crucial importance and the resulting consequences are 
reflected in the values of specificity and sensitivity (97.5 and 99.3% respectively).
Conclusions
In conclusion, this noncontact meibography system is a useful and patient-friendly 
method to obtain information about the meibomian gland structure. Using this mei-
bography system, the authors found that changes in Meibomian glands increase with 
age, develop earlier in men than in women, and are more severe in elderly men than in 
elderly women. The authors hope that this meibography method will contribute to the 
elucidation of the pathologic mechanisms of meibomian gland diseases and will help to 
establish better diagnostic criteria for MGD.
The presented, new method of analysis of Meibomian glands is fully automatic, does 
not require operator’s intervention, allows obtaining reproducible results and enables a 
quantitative assessment of Meibomian glands. Compared to the other known methods, 
particularly with the method described in [41] it allows obtaining better sensitivity and 
Fig. 5 ROC curve for threshold po changed in the range of 0–100%
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specificity results by 2%. Moreover, it additionally enables removing the area occupied 
by the eyelid edge. It can be concluded that the analysis of particular Meibomian glands’ 
location is not an indispensable element and feature. In each case the analysis of per-
centage area occupied by Meibomin glands in relation to the whole surface of the eyelid 
is meaningful and adequate.
Currently, the method is being tested at the Beijing Institute of Ophthalmology, Bei-
jing Tongren Hospital in China.
Fig. 6 Exemplary results allowing the qualitative comparison of two methods: a image with automatically 
marked location of Meibomian glands according to the method described in [41]; b area covering Meibo-
mian glands according to the method described in [41] and c results of analysis described in this article 
(indications complying with indications in b)
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